Soft and Hard Tissue Sarcoma—Current and Future Concepts in Diagnosis and Treatment
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (10 April 2022) | Viewed by 40822
Special Issue Editor
Special Issue Information
Dear Colleagues,
Despite being relatively rare tumors, soft and hard tissue sarcomas contribute to a significant number of patients needing treatment. Diagnostic and treatment concepts for soft and hard tissue sarcomas have advanced in recent years. In this review, established and recently developed diagnostic tools, ranging from new immunohistochemical markers and genetic profiling to liquid biopsies and mRNA-based diagnostics in sarcomas, will be elucidated.
Surgery is the first line of treatment in many sarcoma cases, comprising orthopedic surgery, plastic surgery, as well as general and visceral surgery, often in an interdisciplinary approach. Hence, current concepts for surgical treatment of soft and hard tissue sarcomas of the trunk and extremities, as well as reconstructive options, will be in the focus of the surgical contributions to this Special Issue. We also provide a contribution about the current status of adjuvant chemotherapy, including new biologicals, for the curative and palliative treatment of soft and hard tissue sarcomas. Finally, new innovative approaches for sarcoma disease modelling in vitro and in vivo are highlighted, and future perspectives for experimental models will be outlined.
In summary, the aim of this Special Issue is to highlight recent studies on sarcoma diagnostics, medical and surgical sarcoma treatment, including reconstructive surgery, and future perspectives based on experimental models for sarcoma research.
Prof. Dr. Justus P. Beier
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- soft tissue sarcoma
- hard tissue sarcoma
- imaging in sarcoma diagnostics
- liquid biopsy
- sarcoma treatment
- reconstructive surgery